急性冠状动脉综合征患者合并出血的相关因素分析

目的:探讨急性冠状动脉综合征患者合并出血的相关因素.方法:回顾性分析2012年1月至2015年12月入院的940例急性冠状动脉综合征患者按是否合并出血分为两组,查阅病历报告与医疗文书,分析患者治疗期间合并出血的相关因素.结果:两组患者性别因素方面存在差异,具有统计学意义(P<0.05);年龄因素、糖尿病史、高血压史、高血脂史、心肌梗塞史、消化道溃疡史、心衰史、GPⅡb/Ⅲ受体拮抗剂使用因素与术后肝素使用因素方面存在差异,具有统计学意义(P<0.01);性别、年龄、糖尿病史、高血压史、高血脂史、心肌梗塞史、消化道溃疡史、心衰史、GPⅡb/Ⅲ受体拮抗剂使用因素与术后肝素使用因素的ORmin>1,是急性冠状动脉综合征患者合并出血的危险因素.结论:针对性别、年龄、糖尿病史、高血压史、高血脂史、心肌梗塞史、消化道溃疡史、心衰史、使用GPⅡb/Ⅲ受体拮抗剂与术后未使用肝素的患者,临床上应更为注意出血的发生,控制病情的进一步发展,预防出血发生.

Factors Patients with Acute Coronary Syndrome Bleeding

Objective:To investigate the factors associated with acute coronary syndrome patients with hemorrhage. Method:A retrospective analysis from January 2012 to December 2015 admitted 940 patients with acute coronary syndrome patients divided into two groups according to whether the hemorrhage, medical records and reports of medical instruments and analysis of relevant factors during the treatment of patients with hemorrhage. Result:There are two sets of gender factors in patients with significant difference was statistically significant (P <0.05); factor of age, history of diabetes, history of hypertension, high cholesterol history, history of myocardial infarction, peptic ulcer history, history of heart failure, GPⅡb / receptor antagonists ex-@ist factors associated with postoperative use of heparin factors Ⅲ significant difference was statistically signifi-cant (P <0.01); sex, age, history of diabetes, history of hypertension, high cholesterol history, history of myocardial infarction, digestion Road ulcer history, history of heart failure, GPⅡb / Ⅲ receptor antagonist use ORmin factors associated with postoperative heparin factor> 1, is a risk factor in acute coronary syndrome patients with hemorrhage. Conclusion:for sex, age, history of diabetes, history of hypertension, high choles-terol history, history of myocardial infarction, peptic ulcer history, history of heart failure, the use of GPⅡb /Ⅲ receptor antagonist with no postoperative patients using heparin, the clinical should be more attention to the occurrence of bleeding, control the further development of the disease, prevention of bleeding.